TITLE:
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

CONDITION:
Psoriasis

INTERVENTION:
NONE

SUMMARY:

      The Raptiva Pregnancy Registry was a prospective observational study established to obtain
      data on pregnancy outcomes of women who were exposed to Raptiva.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: N/A to N/A
Criteria:

        Any patient who has used Raptiva within 6 weeks prior to conception or during her
        pregnancy may be included in the Registry. Enrollment is based on Raptiva exposure,
        whether inadvertent or deliberate, in relation to pregnancy. Enrollment should occur as
        early as possible during the pregnancy and must occur prior to knowledge of pregnancy
        outcome.
      
